Published in Nat Genet on February 08, 2009
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Macrophages in the pathogenesis of atherosclerosis. Cell (2011) 7.78
Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One (2010) 7.48
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63
Haplotype phasing: existing methods and new developments. Nat Rev Genet (2011) 4.66
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab (2010) 3.29
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet (2010) 3.15
The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res (2010) 2.44
Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet (2011) 2.27
Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet (2011) 2.21
A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet (2012) 1.81
Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation (2011) 1.77
DASH: a method for identical-by-descent haplotype mapping uncovers association with recent variation. Am J Hum Genet (2011) 1.62
Association of a genetic risk score with prevalent and incident myocardial infarction in subjects undergoing coronary angiography. Circ Cardiovasc Genet (2012) 1.54
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. Pharmacogenet Genomics (2010) 1.48
Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One (2011) 1.43
Telomere biology in healthy aging and disease. Pflugers Arch (2009) 1.41
Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One (2009) 1.36
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet (2012) 1.35
Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet (2011) 1.32
The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia. Eur J Epidemiol (2009) 1.31
Genetic risk score and risk of myocardial infarction in Hispanics. Circulation (2011) 1.30
Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. J Am Coll Cardiol (2011) 1.26
Variation in recovery: Role of gender on outcomes of young AMI patients (VIRGO) study design. Circ Cardiovasc Qual Outcomes (2010) 1.26
Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circ Cardiovasc Genet (2010) 1.23
Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes). J Am Coll Cardiol (2013) 1.23
Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA (2013) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. Eur Heart J (2011) 1.20
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. J Lipid Res (2010) 1.18
Genetic cardiovascular risk prediction: will we get there? Circulation (2010) 1.17
Genome-wide association studies: quality control and population-based measures. Genet Epidemiol (2009) 1.14
Systematic haplotype analysis resolves a complex plasma plant sterol locus on the Micronesian Island of Kosrae. Proc Natl Acad Sci U S A (2009) 1.13
Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts. PLoS One (2012) 1.13
Mendelian randomization: nature's randomized trial in the post-genome era. JAMA (2009) 1.11
Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease risk. BMC Med Genet (2011) 1.09
Coronary heart disease is associated with a mutation in mitochondrial tRNA. Hum Mol Genet (2013) 1.08
Large scale association analysis identifies three susceptibility loci for coronary artery disease. PLoS One (2011) 1.07
Molecular basis of obesity: current status and future prospects. Curr Genomics (2011) 1.07
Next generation sequencing in cardiovascular diseases. World J Cardiol (2012) 1.04
Utility of genetic determinants of lipids and cardiovascular events in assessing risk. Nat Rev Cardiol (2011) 1.04
Genome-wide haplotype analysis of cis expression quantitative trait loci in monocytes. PLoS Genet (2013) 1.03
Stem cell models of cardiac development and disease. Annu Rev Cell Dev Biol (2010) 1.03
Efficient haplotype block recognition of very long and dense genetic sequences. BMC Bioinformatics (2014) 1.01
Genetics of coronary artery disease. Circulation (2013) 1.00
Implications of discoveries from genome-wide association studies in current cardiovascular practice. World J Cardiol (2011) 0.97
A systems biology approach to understanding atherosclerosis. EMBO Mol Med (2010) 0.97
Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet. J Lipid Res (2010) 0.95
Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study. BMC Med Genet (2013) 0.95
Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest (2011) 0.94
Impact of APOE gene polymorphisms on the lipid profile in an Algerian population. Lipids Health Dis (2013) 0.94
RNAi-based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function. PLoS Genet (2013) 0.94
From genotype to phenotype in human atherosclerosis--recent findings. Curr Opin Lipidol (2013) 0.93
Genetics of diabetes complications. Curr Diab Rep (2010) 0.93
Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk. Stroke (2010) 0.92
Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials. Arterioscler Thromb Vasc Biol (2015) 0.92
Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke. Eur J Neurol (2012) 0.91
Genetic causes of myocardial infarction: new insights from genome-wide association studies. Dtsch Arztebl Int (2010) 0.90
Genetic and clinical correlates of early-outgrowth colony-forming units. Circ Cardiovasc Genet (2011) 0.89
Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population. Ann Hum Genet (2011) 0.89
Genome-wide association analysis of incident coronary heart disease (CHD) in African Americans: a short report. PLoS Genet (2011) 0.89
Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun (2016) 0.88
A genome-wide scan for breast cancer risk haplotypes among African American women. PLoS One (2013) 0.87
Molecular genetics of coronary artery disease. J Hum Genet (2015) 0.87
Association between genetics of diabetes, coronary artery disease, and macrovascular complications: exploring a common ground hypothesis. Rev Diabet Stud (2011) 0.87
The Association Study between Twenty One Polymorphisms in Seven Candidate Genes and Coronary Heart Diseases in Chinese Han Population. PLoS One (2013) 0.86
Implications of genetic polymorphisms in inflammation-induced atherosclerosis. Open Cardiovasc Med J (2010) 0.86
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases. Cardiovasc Drugs Ther (2016) 0.86
Hypothesis-based analysis of gene-gene interactions and risk of myocardial infarction. PLoS One (2012) 0.86
Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease. PPAR Res (2009) 0.86
Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. Pharmacogenomics J (2012) 0.86
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis. PLoS One (2012) 0.85
A latent variable partial least squares path modeling approach to regional association and polygenic effect with applications to a human obesity study. PLoS One (2012) 0.85
Pathway analysis of body mass index genome-wide association study highlights risk pathways in cardiovascular disease. Sci Rep (2015) 0.85
Genome-wide association studies in atherosclerosis. Curr Atheroscler Rep (2011) 0.84
Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics. Trends Cardiovasc Med (2009) 0.84
Structure, function, and genetics of lipoprotein (a). J Lipid Res (2016) 0.83
The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular disease. EMBO Mol Med (2016) 0.83
Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study. Lipids Health Dis (2012) 0.83
Genome-wide association study of coronary artery disease. Int J Hypertens (2010) 0.83
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. J Lipid Res (2016) 0.83
Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. Hum Mol Genet (2015) 0.83
Genetics of coronary artery disease: focus on genome-wide association studies. Am J Transl Res (2009) 0.83
Towards a molecular systems model of coronary artery disease. Curr Cardiol Rep (2014) 0.82
Extraneuronal monoamine transporter mediates the permissive action of cortisol in the Guinea pig trachea: possible involvement of tracheal chondrocytes. PLoS One (2013) 0.82
Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice. J Lipid Res (2012) 0.82
Characterization of Ath29, a major mouse atherosclerosis susceptibility locus, and identification of Rcn2 as a novel regulator of cytokine expression. Am J Physiol Heart Circ Physiol (2011) 0.81
Lipoprotein(a) and cardiovascular disease in diabetic patients. Clin Lipidol (2012) 0.81
Mitochondrial tRNA variants in Chinese subjects with coronary heart disease. J Am Heart Assoc (2014) 0.81
A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis. BMC Med Genet (2013) 0.80
Lipoprotein(a) for risk assessment in patients with established coronary artery disease. J Am Coll Cardiol (2013) 0.80
Pharmacogenomics of membrane transporters: past, present and future. Pharmacogenomics (2010) 0.80
Contribution of large region joint associations to complex traits genetics. PLoS Genet (2015) 0.80
Genetic prediction of common diseases. Still no help for the clinical diabetologist! Nutr Metab Cardiovasc Dis (2012) 0.80
Common genetic variants and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2015) 0.80
A solute carrier family 22 member 3 variant rs3088442 G→A associated with coronary heart disease inhibits lipopolysaccharide-induced inflammatory response. J Biol Chem (2015) 0.80
Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma. Indian J Med Paediatr Oncol (2011) 0.80
Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction. Atherosclerosis (2016) 0.79
Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies. Cardiovasc Diabetol (2012) 0.79
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Genomewide association analysis of coronary artery disease. N Engl J Med (2007) 24.38
KORA-gen--resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen (2005) 7.93
PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet (2006) 4.72
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Haplotypic analysis of Wellcome Trust Case Control Consortium data. Hum Genet (2008) 2.92
Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation (2005) 2.81
Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. Circulation (2003) 1.49
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb (1992) 1.45
Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study. Atherosclerosis (1999) 1.22
Building an infrastructure for scientific Grid computing: status and goals of the EGEE project. Philos Trans A Math Phys Eng Sci (2005) 1.16
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Genomewide association analysis of coronary artery disease. N Engl J Med (2007) 24.38
Origins and functional impact of copy number variation in the human genome. Nature (2009) 23.63
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet (2007) 19.04
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet (2008) 16.92
Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet (2006) 15.14
A common genetic variant is associated with adult and childhood obesity. Science (2006) 14.95
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron (2004) 14.35
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25